News and Updates

On February 15, 2019, Stealth Biotherapeutics, the company founded by Dr. Hazel Szeto, a WCM Pharmacology professor, ~ 12 years ago, priced its IPO today of 6.5M ADSs, each representing 12 ordinary shares of Stealth, at a price of $12.00/ADS, for expected gross proceeds of $78M.

Drs. Zippin, Buck, and Levin publish a groundbreaking study on how skin color is established.

To read the article, click here.

Dr. Jaffrey Co-Founds a New Biotech Company.

To read more, click here.

Dr. Quintero's Research is Published!

Dr. Cynthia Quintero, PhD student mentored by Drs. Gudas and Luo, published her research on CARM1! Here is the link: click here.

Pathway to Stop Diabetes Visionary Award Recipient

Weill Cornell Faculty member, Dr. Samie R. Jaffrey has received the Pathway Visionary Award for his basic research project titled, "Rewiring Cellular Metabolic Networks in Diabetes." Dr. Jaffrey is developing a new type of gene therapy that will allow liver cells to "sense" metabolic abnormalities that occur in diabetes and then stimulate the production of proteins that would correct liver function.

Tom Rossetti won the first year poster prize in the 38th annual Vincent du Vigneaud Research Symposium from his work in Dr. Kristen Pleil’s lab.